Yet Kwong Horman Julian, Schultz Michael
Internal Medicine-Pediatrics, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
Cureus. 2022 Jul 13;14(7):e26804. doi: 10.7759/cureus.26804. eCollection 2022 Jul.
We present a case of a 59-year-old woman who had been recently diagnosed with a cavitary lung nodule and then started on voriconazole; she had been diagnosed with breast cancer about 10 years prior, which had been treated with anthracyclines and subsequent non-ischemic cardiomyopathy, ultimately requiring an orthotopic heart transplant. She presented to the hospital due to nausea and abdominal pain. She was found to have cholelithiasis, without cholecystitis, and was initially discharged with plans for an outpatient cholecystectomy. However, nausea and pain persisted, and hence she was readmitted and had a cholecystectomy but her nausea continued. Further workup revealed an elevated voriconazole level, and her nausea resolved once the voriconazole was discontinued.
我们报告一例59岁女性病例,该患者最近被诊断为肺空洞结节,随后开始使用伏立康唑治疗;她大约在10年前被诊断出患有乳腺癌,接受了蒽环类药物治疗,随后出现非缺血性心肌病,最终需要进行原位心脏移植。她因恶心和腹痛入院。检查发现她有胆结石,但无胆囊炎,最初出院时计划进行门诊胆囊切除术。然而,恶心和疼痛持续存在,因此她再次入院并接受了胆囊切除术,但恶心仍未缓解。进一步检查发现伏立康唑水平升高,停用伏立康唑后恶心症状消失。